RE:RE:RE:RE:Will MCNA soon be obsolete?Stock prices make no sense! Look at EDIT (gene splicing co with Bill Gates et al backing)...sitting at ~U$40: they're in a legal battle for the patents for their technology, no specific disease to address, and no clinical trials in the works for at least 2 years...and there they sit with a U$1B market cap. And here's TST scratching and clawing to survive with a successful proven drug for a cancer desperate for a treatment and a worldwide shortage of the 1st line therapy to boot. That's why I said there's no logic or rationality to this situation with the FDA...and SP/market caps don't reflect any relationship with reality!!! You can have the best management in the world (doesn't often happen), but without all the other tangibles (timely product etc.) and intangibles (confidence from investors is so unpredictable), it's not going to happen. I clearly understand TST messed up their AdCom presentation and have to carry some of the responsibility for this muddled path, but at best, FDA approval appears to be a crapshoot if you're not US Big Pharma. It is what it is.